Shortness of Breath on Day 1 After Surgery Alerting the Presence of Early Respiratory Complications After Surgery in Lung Cancer Patients

Overview

Journal Patient Prefer Adherence

Date 2022 Mar 28

PMID 35340757

Authors

Qingsong Yu

Hongfan Yu

Wei Xu

Yang Pu

Yuxian Nie

Wei Dai

Xing Wei

Xin Shelley Wang

Charles S Cleeland

Qiang Li

Qiuling Shi

Affiliations

Soon will be listed here.

Abstract

Purpose: Patient-reported outcome (PRO)-based symptom assessment with a threshold can facilitate the early alert of adverse events. The purpose of this study was to determine whether shortness of breath (SOB) on postoperative day 1 (POD1) can inform postoperative pulmonary complications (PPCs) for patients after lung cancer (LC) surgery.

Methods: Data were extracted from a prospective cohort study of patients with LC surgery. Symptoms were assessed by the MD Anderson Symptom Inventory-lung cancer module (MDASI-LC) before and daily after surgery. Types and grades of complications during hospitalization were recorded. SOB and other symptoms were tested for a possible association with PPCs by logistic regression models. Optimal cutpoints of SOB were derived, using the presence of PPCs as an anchor.

Results: Among 401 patients with complete POD1 MDASI-LC and records on postoperative complications, 46 (11.5%) patients reported Clavien-Dindo grade II-IV PPCs. Logistic regression revealed that higher SOB score on POD1 (odds ratio [OR]=1.13, 95% CI=1.01-1.27), male (OR=2.86, 95% CI=1.32-6.23), open surgery (OR=3.03, 95% CI=1.49-6.14), and lower forced expiratory volume in one second (OR=1.78, 95% CI=1.66-2.96) were significantly associated with PPCs. The optimal cutpoint was 6 (on a 0-10 scale) for SOB. Patients reporting SOB < 6 on POD1 had shorter postoperative length of stay than those reporting 6 or greater SOB (median, 6 vs 7, P =0.007).

Conclusion: SOB on POD1 can inform the onset of PPCs in patients after lung cancer surgery. PRO-based symptom assessment with a clinically meaningful threshold could alert clinicians for the early management of PPCs.

Citing Articles

Long-Term Function Recovery Following Upper Versus Lower Lobectomy for Lung Cancer: A Multicenter Longitudinal Cohort Study.

Wei X, Yu H, King-Kallimanis B, Liu Y, Huang L, Dai W Thorac Cancer. 2024; 16(1):e15505.

PMID: 39670353 PMC: 11734611. DOI: 10.1111/1759-7714.15505.

Comparing the Efficacy of Empirical Anti-Infective Therapy and Follow-Up Observation for Newly Diagnosed Pulmonary Ground-Glass Nodules With Suspected Inflammatory Etiology: A Multicenter Prospective Observational Study Protocol.

Feng W, He T, Zhang Y, Mu Y, Pu Y, Liu Y Health Sci Rep. 2024; 7(11):e70201.

PMID: 39540029 PMC: 11558264. DOI: 10.1002/hsr2.70201.

Surgical intervention of a giant bronchogenic cyst in the right middle lobe with recurrent infections: a case report.

Qiao Q, Wen H, Chen X, Tu C, Zhang X, Wei X J Surg Case Rep. 2024; 2024(10):rjae664.

PMID: 39439813 PMC: 11495328. DOI: 10.1093/jscr/rjae664.

Shortness of breath on the day of discharge: an early alert for post-discharge complications in patients undergoing lung cancer surgery.

Kang D, Lei C, Zhang Y, Wei X, Dai W, Xu W J Cardiothorac Surg. 2024; 19(1):398.

PMID: 38937786 PMC: 11210099. DOI: 10.1186/s13019-024-02845-1.

Efficacy of a smartphone application assisting home-based rehabilitation and symptom management for patients with lung cancer undergoing video-assisted thoracoscopic lobectomy: a prospective, single-blinded, randomised control trial (POPPER study).

Lv C, Lu F, Zhou X, Li X, Yu W, Zhang C Int J Surg. 2024; 111(1):597-608.

PMID: 38905505 PMC: 11745689. DOI: 10.1097/JS9.0000000000001845.

References

Hu X, Xu S, Wang X, Luo J, Hou D, Zhang X . Development and validation of nomogram estimating post-surgery hospital stay of lung cancer patients: relevance for predictive, preventive, and personalized healthcare strategies. EPMA J. 2019; 10(2):173-183. PMC: 6562016. DOI: 10.1007/s13167-019-00168-z. View

Mendoza T, Wang X, Lu C, Palos G, Liao Z, Mobley G . Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist. 2011; 16(2):217-27. PMC: 3228083. DOI: 10.1634/theoncologist.2010-0193. View

Parshall M, Schwartzstein R, Adams L, Banzett R, Manning H, Bourbeau J . An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012; 185(4):435-52. PMC: 5448624. DOI: 10.1164/rccm.201111-2042ST. View

Pezzuto A, Spoto C, Vincenzi B, Tonini G . Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level. J Comp Eff Res. 2013; 2(3):335-43. DOI: 10.2217/cer.13.25. View

van den Beuken-van Everdingen M, de Rijke J, Kessels A, Schouten H, van Kleef M, Patijn J . Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007; 18(9):1437-49. DOI: 10.1093/annonc/mdm056. View

Sarna L, Cooley M, Brown J, Chernecky C, Elashoff D, Kotlerman J . Symptom severity 1 to 4 months after thoracotomy for lung cancer. Am J Crit Care. 2008; 17(5):455-67. PMC: 6674975. View

Hirschfeld G, Zernikow B . Variability of "optimal" cut points for mild, moderate, and severe pain: neglected problems when comparing groups. Pain. 2012; 154(1):154-159. DOI: 10.1016/j.pain.2012.10.008. View

Johnson M, Currow D, Booth S . Prevalence and assessment of breathlessness in the clinical setting. Expert Rev Respir Med. 2014; 8(2):151-61. DOI: 10.1586/17476348.2014.879530. View

Dai W, Feng W, Zhang Y, Wang X, Liu Y, Pompili C . Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial. J Clin Oncol. 2022; 40(9):988-996. PMC: 8937008. DOI: 10.1200/JCO.21.01344. View

10.

Ha D, Ries A . Characterization of Dyspnea in Veteran Lung Cancer Survivors Following Curative-Intent Therapy. J Cardiopulm Rehabil Prev. 2019; 40(2):120-127. PMC: 7285629. DOI: 10.1097/HCR.0000000000000464. View

11.

Reponen E, Korja M, Tuominen H . Simple Preoperative Patient-Reported Factors Predict Adverse Outcome After Elective Cranial Neurosurgery. Neurosurgery. 2017; 83(2):197-202. DOI: 10.1093/neuros/nyx385. View

12.

Smetana G, Lawrence V, Cornell J . Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med. 2006; 144(8):581-95. DOI: 10.7326/0003-4819-144-8-200604180-00009. View

13.

Serpa Neto A, Hemmes S, S V Barbas C, Beiderlinden M, Fernandez-Bustamante A, Futier E . Incidence of mortality and morbidity related to postoperative lung injury in patients who have undergone abdominal or thoracic surgery: a systematic review and meta-analysis. Lancet Respir Med. 2014; 2(12):1007-15. DOI: 10.1016/S2213-2600(14)70228-0. View

14.

Fagundes C, Shi Q, Vaporciyan A, Rice D, Popat K, Cleeland C . Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory. J Thorac Cardiovasc Surg. 2015; 150(3):613-9.e2. PMC: 4554973. DOI: 10.1016/j.jtcvs.2015.05.057. View

15.

Brunelli A, Drosos P, Dinesh P, Ismail H, Bassi V . The Severity of Complications Is Associated With Postoperative Costs After Lung Resection. Ann Thorac Surg. 2017; 103(5):1641-1646. DOI: 10.1016/j.athoracsur.2016.10.061. View

16.

Wang X, Zhao F, Fisch M, OMara A, Cella D, Mendoza T . Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014; 120(3):425-32. PMC: 3949157. DOI: 10.1002/cncr.28434. View

17.

Efficace F, Cartoni C, Niscola P, Tendas A, Meloni E, Scaramucci L . Predicting survival in advanced hematologic malignancies: do patient-reported symptoms matter?. Eur J Haematol. 2012; 89(5):410-6. DOI: 10.1111/ejh.12004. View

18.

Chow E, Ding K, Parulekar W, Wong R, van der Linden Y, Roos D . Revisiting classification of pain from bone metastases as mild, moderate, or severe based on correlation with function and quality of life. Support Care Cancer. 2015; 24(4):1617-23. DOI: 10.1007/s00520-015-2957-5. View

19.

Dai W, Xie S, Zhang R, Wei X, Wu C, Zhang Y . Developing and validating utility parameters to establish patient-reported outcome-based perioperative symptom management in patients with lung cancer: a multicentre, prospective, observational cohort study protocol. BMJ Open. 2019; 9(10):e030726. PMC: 6830688. DOI: 10.1136/bmjopen-2019-030726. View

20.

Oldenmenger W, de Raaf P, de Klerk C, van der Rijt C . Cut points on 0-10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review. J Pain Symptom Manage. 2012; 45(6):1083-93. DOI: 10.1016/j.jpainsymman.2012.06.007. View